Immunologic profile of patients with fibromyalgia

American Journal of Physical Medicine and Rehabilitation

Volumn 76, Issue 3, 1997, Pages 231-234

  Smart, Paulette A ^a   Waylonis, George W ^a,b   Hackshaw, Kevin V ^a,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Antinuclear Antibodies; Autoimmune; Fibromyalgia; Sedimentation Rate; Systemic Lupus

Indexed keywords

ANTIBODIES; BLOOD; IMMUNOLOGY;

ANTINUCLEAR ANTIBODY; FIBROMYALGIA; SMART INDEX (SI);

MUSCULOSKELETAL SYSTEM;

ANTINUCLEAR ANTIBODY;

ARTICLE; FIBROMYALGIA; HUMAN; IMMUNOPATHOLOGY; PREVALENCE; SEDIMENTATION RATE;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; BLOOD SEDIMENTATION; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0031149466     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-199705000-00014     Document Type: Article

References (13)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multi centre criteria committee. Arthritis Rheum 1990;33:160-172.
2. Waylonis GW, Perkins RH: Post-traumatic fibromyalgia: a long term follow-up. Am J Phys Med Rehabil 1994;73:403-412.
3. Goldenberg DL: Fibromalgia syndrome. JAMA 1987;257:2782-2787.
4. Bridges AJ: Fibromyalgia, antinuclear antibodies and clinical features of connective tissue diseases (letter). Clin Exp Rheumatol 1993;11:696-697.
5. Dinnerrnan H, Goldenberg DL, Felston DT: A prospective evaluation of 118 patients with fibromyalgia syndrome: preva- lence of Raynaud's phenomena, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermoid junction. J Rheumatol 1986;13:368-373.
6. Hackshaw KV, Shi Y, Brandwein SR, Jones K, Westcott JY: A pilot study of Zileuton, a novel selective 5-lipoxygenase inhibitor in patients with systemic Iupus erythematosus. J Rheumatol 1995;22:462-468.
7. Schmerling RH, Liang MH: Laboratory evaluation of rheumatic diseases, in Schumacher RH Jr, Kippel JH, Koopman WJ (eds): Primer of Rheumatic Diseases, ed 10. Atlanta, Arthritis Foundation, 1993:64-66.
8. Sox HC Jr, Liang MH: The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 1986;104:515-523.
9. Gladman DD, Urowitz MB: Systemic Iupus erythematosus: Clinical features, in Schumacher RH Jr, Kippel JH, Koopman WJ (eds): Primer of Rheumatic Diseases, ed 10. Atlanta, Arthritis Foundation, 1993:106-111.
10. McCarty GA: Autoantibodies and their relationship to rheumatic disease. Med Clin North Am 1986;70:237-261.
11. Bengston A, Ernerudh J, Vrethem M, Skogh T: Absence of autoantibodies in primary fibromyalgia. J Rheumatol 1990;17:1682-1683.
12. Middleton GB, McFarlin JE, Lipsky PE: The prevalence and clinical impact of fibromyalgia in systemic Iupus erythematosus. Arthritic Rheum 1994;37:1181-1188.
13. Juby A, Johnston C, Davis P: Specificity, sensitivity and diagnostic predictive value of selected autoantibody profiles in patients with connective tissue diseases. J Rheumatol 1991;18:354-358.